COMBINATION THERAPY WITH CYCLOSPORIN AND METHOTREXATE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS SOON IN HIBITS TNF-ALFA PRODUCTION WITHOUT DECREASING TNF-ALFA mRNA LEVELS. AND IN VIVO AND IN VITRO STUDY